This is an old revision of this page, as edited by CheMoBot (talk | contribs) at 13:47, 24 February 2011 (Updating {{chembox}} (changes to verified fields - updated 'UNII_Ref', 'ChEMBL_Ref', 'KEGG_Ref') per Chem/Drugbox validation (report errors or [[user talk). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 13:47, 24 February 2011 by CheMoBot (talk | contribs) (Updating {{chembox}} (changes to verified fields - updated 'UNII_Ref', 'ChEMBL_Ref', 'KEGG_Ref') per Chem/Drugbox validation (report errors or [[user talk)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)Names | |
---|---|
IUPAC name 1-(8-methoxy-2,3-dihydro-1,4-benzodioxin-6-yl)propan-2-amine | |
Identifiers | |
CAS Number | |
3D model (JSmol) | |
ChemSpider | |
KEGG | |
PubChem CID | |
InChI
| |
SMILES
| |
Properties | |
Chemical formula | C12H17NO3 |
Molar mass | 223.268 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa). N verify (what is ?) Infobox references |
MEDA, or 3-methoxy-4,5-ethylenedioxyamphetamine, is a lesser-known psychedelic drug. MEDA was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 200 mg, and the duration unknown. MEDA produces few to no effects. Very little data exists about the pharmacological properties, metabolism, and toxicity of MEDA.
See also
External links
This psychoactive drug-related article is a stub. You can help Misplaced Pages by expanding it. |